Browse 26479 Federal Health Grants below, sorted by the deadline to apply.
The United States Government agency or department offering the grant is also listed.
Select a specific Health grant to read the full description of the opportunity.
The full description contains the grant type, total award amount, eligible applicants, important dates, and official contact details.
If you wish to search for a specific keyword or view grants sorted by governmental agency, use the links on the menu bar.
| Close Date | Grant Title | Agency |
| January 7th, 2028 |
Tobacco, Alcohol, and Cannabis Policy Research for Health Equity (R01 Clinical Trial Optional) |
National Institutes of Health |
| June 22nd, 2026 |
Digital Health Technology Derived Biomarkers and Outcome Assessments for Remote Monitoring and Endpoint Development (UG3/UH3 - Clinical Trial Optional) |
National Institutes of Health |
| January 10th, 2025 |
NIMHD Minority Health and Health Disparities Research Training (MHRT) Program (T37 Clinical Trial Not Allowed) |
National Institutes of Health |
| January 7th, 2027 |
National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required) |
National Institutes of Health |
| January 7th, 2027 |
Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required) |
National Institutes of Health |
| September 5th, 2027 |
NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional) |
National Institutes of Health |
| January 7th, 2028 |
NIDCR Dentist Scientist Career Transition Award for Intramural Investigators (K22 Clinical Trial Not Allowed) |
National Institutes of Health |
| May 7th, 2025 |
Microbial-based Cancer Imaging and Therapy - Bugs as Drugs (R21 Clinical Trial Not Allowed) |
National Institutes of Health |
| January 7th, 2028 |
Integrating Mental Health Care into Health Care Systems and Non-Health Settings in Low- and Middle-Income Countries (R01 Clinical Trial Optional) |
National Institutes of Health |
| January 7th, 2027 |
Improving Care and Outcomes for Cancer Survivors from Sexual and Gender Minority (SGM) Populations (R01 Clinical Trial Optional) |
National Institutes of Health |
| September 7th, 2028 |
Exploratory Grants in Cancer Control (R21 Clinical Trial Optional) |
National Institutes of Health |
| March 10th, 2025 |
NINDS Exploratory Clinical Trials (UG3/UH3 Clinical Trial Required) |
National Institutes of Health |
| February 24th, 2025 |
NIOSH Underground Mine Evacuation Technologies and Human Factors Research |
Centers for Disease Control and Prevention - ERA |
| March 6th, 2026 |
NIH SIREN Neurologic Clinical Trials (UG3/UH3 - Clinical Trial Required) |
National Institutes of Health |
| January 7th, 2028 |
NINDS Ruth L. Kirschstein National Research Service Award (NRSA) for Training of Postdoctoral Fellows (F32 Clinical Trial Not Allowed) |
National Institutes of Health |
| January 7th, 2028 |
Laboratories to Optimize Digital Health (R01 Clinical Trial Required) |
National Institutes of Health |
| December 2nd, 2025 |
Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinary Aging Studies (R33 Clinical Trial Optional) |
National Institutes of Health |
| December 2nd, 2025 |
Research Infrastructure Development for Interdisciplinary Aging Studies (R61/R33 - Clinical Trial Optional) |
National Institutes of Health |
| January 7th, 2028 |
Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional) |
National Institutes of Health |
| December 9th, 2024 |
USAID Thamini Afya (Value your Health) |
Tanzania USAID-Dar es Salaam |
|
| January 7th, 2027 |
Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional) |
National Institutes of Health |
| May 7th, 2026 |
Assay Development and Screening for Discovery of Validated Chemical Hits for Brain Disorders (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
| September 7th, 2027 |
Bioengineering Partnerships with Industry (U01 Clinical Trial Optional) |
National Institutes of Health |
| January 7th, 2027 |
Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional) |
National Institutes of Health |
| January 7th, 2026 |
Engineering Next-Generation Human Nervous System Microphysiological Systems (R01 Clinical Trials Not Allowed) |
National Institutes of Health |
| January 7th, 2026 |
Engineering Next-Generation Human Nervous System Microphysiological Systems (R21 Clinical Trials Not Allowed) |
National Institutes of Health |
| January 7th, 2028 |
Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional) |
National Institutes of Health |
| September 7th, 2026 |
Assay development and screening for discovery of chemical probes, drugs or immunomodulators (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
| January 7th, 2028 |
Research With Activities Related to Diversity (ReWARD) (R01 Clinical Trial Optional) |
National Institutes of Health |
| January 7th, 2028 |
Natural History of Disorders Screenable in the Newborn Period (R01 Clinical Trial Optional) |
National Institutes of Health |
| January 7th, 2026 |
In-Depth Phenotyping and Research Using IMPC-Generated Knockout Mouse Strains Exhibiting Embryonic or Perinatal Lethality or Subviability (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
| September 7th, 2025 |
Advancing Research to Understand Congenital Malformations (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
| May 7th, 2026 |
Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Optional) |
National Institutes of Health |
| September 7th, 2026 |
Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
| January 6th, 2028 |
Stimulating Hematology Investigation: New Endeavors (SHINE) (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
| January 7th, 2028 |
Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional) |
National Institutes of Health |
| January 7th, 2028 |
Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
| January 7th, 2026 |
NIA Multi-site Clinical Trial Implementation Grant (R01 Clinical Trial Required) |
National Institutes of Health |
| November 12th, 2027 |
NIA Academic Leadership Career Award (K07 Independent Clinical Trial Not Allowed) |
National Institutes of Health |
| February 27th, 2025 |
Engaging Loved ones in Recovery Processes to Enhance Recovery Capital and Outcomes (R61/R33 Clinical Trial Optional) |
National Institutes of Health |
